Heidi Kay

Heidi Kay is the Founder and CEO of Jericho Sciences, LLC. She holds a strong patent portfolio in therapeutics and has extensive experience in disease models. She is the Lead Inventor for a number of novel antiviral and anticancer therapeutic molecules and associated diagnostic methods, initially as a faculty member at the University of South Florida, and later through independent collaborative studies.

Dr. Kay’s research focus is toward curative strategies for HIV-1 infection, including strategies for long term remission of virus-associated pathologies. This work has been supported through federal NIH small business funding since 2010, following the founding of Jericho Sciences in 2009.

Dr. Kay earned her Ph.D. in Physical Chemistry in 1999 at the University of South Florida (Tampa) under the Distinguished Professor, Dr. Brian Stevens. With over 30 years of research and biotechnology experience, Dr. Kay is committed and determined to improve therapeutic management of HIV infection for the millions of people living with HIV-1 infection.